Concerns about quality control and data integrity have focused on companies in India and China, where more and more ingredients used in medicine for the U.S. are being made. But those concerns aren’t limited to overseas factories, according to a year-long investigation into FDA’s regulation of the generic-drug industry.

Brexit is unlikely to feature in the annals of military history, but Britain is getting a taste of wartime stockpiling again.

Four weeks into the federal government shutdown, a new worry has emerged: the U.S. Food and Drug Administration’s food-safety inspections.

In the nascent world of global pot investing and sourcing, assets can be hard to document — but may hold enormous rewards.

U.S. and Chinese officials are set to begin trade negotiations on Monday in the hope of reaching a deal during a 90-day truce between President Donald Trump and Xi Jinping.

In ways both small and large, businesses are beginning to feel the bite of the government funding impasse that has shuttered nine major departments.

China’s plan to drive down generic drug prices through a centralized bulk procurement program is set to redraw the industry.